Cipher Pharmaceuticals Inc. (FRA:PHE)

Cipher Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	50.06	33.36	21.16	20.68	21.94	21.61
Revenue Growth (YoY)	89.17%	57.66%	2.36%	-5.78%	1.55%	-3.76%
Cost of Revenue	12.85	9.26	4.07	3.99	3.68	3.06
Gross Profit	37.2	24.1	17.09	16.68	18.26	18.55
Selling, General & Admin	17.47	12.24	5.43	4.55	5.11	6.26
Research & Development	0.02	-	0.14	0.1	0.09	0.13
Operating Expenses	24.43	16.26	6.79	5.63	5.2	6.39
Operating Income	12.77	7.85	10.3	11.05	13.06	12.16
Interest Expense	-1.6	-	-	-	-0.08	-0.32
Interest & Investment Income	-	0.33	1.87	0.46	-	0.03
Currency Exchange Gain (Loss)	-0.63	-2.51	0.78	-0.04	0.08	0.09
Other Non Operating Income (Expenses)	-	-	-	-	0.01	0
EBT Excluding Unusual Items	10.55	5.67	12.95	11.48	13.07	11.97
Merger & Restructuring Charges	-0.98	-2.72	-0.27	-	-	-0.15
Gain (Loss) on Sale of Assets	0.13	-	-	-	-0.76	-
Asset Writedown	-	-	-	-	-	-5.28
Legal Settlements	-	-	-	-	-1.25	-
Pretax Income	9.7	2.96	12.68	11.48	11.06	6.54
Income Tax Expense	-7.67	-8.59	-7.7	-15.16	3.3	2.15
Earnings From Continuing Operations	17.36	11.55	20.38	26.64	7.76	4.39
Earnings From Discontinued Operations	-	-	-	-	-	0.16
Net Income	17.36	11.55	20.38	26.64	7.76	4.55
Net Income to Common	17.36	11.55	20.38	26.64	7.76	4.55
Net Income Growth	9.50%	-43.36%	-23.48%	243.34%	70.54%	40.31%
Shares Outstanding (Basic)	26	25	25	25	27	27
Shares Outstanding (Diluted)	26	25	25	26	27	27
Shares Change (YoY)	4.82%	-0.79%	-1.46%	-3.84%	-1.96%	1.52%
EPS (Basic)	0.68	0.47	0.82	1.05	0.29	0.17
EPS (Diluted)	0.67	0.46	0.80	1.03	0.29	0.17
EPS Growth	5.80%	-42.50%	-22.33%	255.17%	74.74%	37.45%
Free Cash Flow	29.87	-60.5	15.86	10.64	13.81	11.68
Free Cash Flow Per Share	1.15	-2.40	0.62	0.41	0.52	0.43
Gross Margin	74.32%	72.25%	80.77%	80.69%	83.21%	85.85%
Operating Margin	25.52%	23.52%	48.68%	53.45%	59.51%	56.30%
Profit Margin	34.69%	34.60%	96.32%	128.83%	35.35%	21.05%
Free Cash Flow Margin	59.68%	-181.33%	74.92%	51.48%	62.95%	54.06%
EBITDA	19.53	11.69	11.44	11.95	13.66	13.22
EBITDA Margin	39.02%	35.04%	54.06%	57.80%	62.25%	61.19%
D&A For EBITDA	6.76	3.84	1.14	0.9	0.6	1.06
EBIT	12.77	7.85	10.3	11.05	13.06	12.16
EBIT Margin	25.52%	23.52%	48.68%	53.45%	59.51%	56.30%
Effective Tax Rate	-	-	-	-	29.85%	32.90%
Revenue as Reported	50.06	33.36	21.16	20.68	21.94	21.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.